BioSpace News Archive

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that Brian Varnum , Ph.D., President and Chief Development Officer, will participate in a panel discussion on

New Indian regulatory approval received for its cryoablation technology to destroy tumors in extensive indications, including for breast, lung, bone and kidney cancer

INO-4800 Phase 2/3 U.S. clinical trial being prepared to start this summer Parallel preclinical challenge studies ongoing

NeuroOne Medical Technologies Corporation, a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces the appointment of Vanessa Tolosa to its Scientific Advisory Board.

LabShares Newton, a shared office and laboratory incubator for emerging biotechnology and life science companies, today announced that it has selected three startup companies developing COVID-19 diagnostics to receive free lab space

Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced the appointment of Brian A. Walter , Ph.D., as Vice President of Regulatory Affairs. Dr. Walter will provide oversight for all U.S. and international regulatory strate

CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions in China and other markets, has appointed Richard J. Gregory , PhD to the position of Acting Chief Scientific Officer. Dr.

INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, announced today that RJ Tesi, MD, CEO and CMO of INmune Bio will participate on a COVID-19 therapeutics panel discussion, at Maxim Group’s Infectious Disease Virtual Conference at 3:45pm ET, on Tuesday, May 5, 2020. Dr. Tesi will discuss treating COVID-19 as an inflammatory d

The easy-to-clean, glove-operable touchpad can help everyone from first responders to medical staff to average citizens help fight the spread of COVID-19

A newly released survey from a 20-year-old Denver-based research, evaluation and strategic consulting firm, Corona Insights, finds Coloradans were more worried a few weeks ago about COVID-19’s impact on the economy than they were about the threat the virus poses to their health or their family’s health.